Education
About Us
Working with TipRanks
Follow Us
Vireo Growth (VREOF)
OTHER OTC:VREOF
VREOF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.23 - $0.69
Previous CloseN/A
Volume345.43K
Average Volume (3M)114.19K
Market Cap
$420.10M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)77.03M
Price to Earnings (P/E)―
Beta0.31
Next Earnings
Aug 07, 2025Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding925,467,830
10 Day Avg. Volume75,957
30 Day Avg. Volume114,194
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$0.55Price Target Upside30.95% Upside
Rating ConsensusHold
Number of Analyst Covering0
Vireo Growth News
PremiumCompany Announcements
Vireo Growth Holds Annual Shareholder Meeting
PremiumCompany Announcements
Vireo Growth Completes Major Merger in Cannabis Sector
PremiumCompany Announcements
Vireo Growth Completes Acquisition of Deep Roots
PremiumCompany Announcements
Vireo Growth Completes Acquisition of Deep Roots Holdings
PremiumCompany Announcements
Vireo Growth Inc. Completes Acquisition of Proper Brands in MissouriOptions Prices
Currently, No data available
---
Ownership Overview
VREOF FAQ
What was Vireo Growth’s price range in the past 12 months?
Vireo Growth lowest stock price was $0.23 and its highest was $0.69 in the past 12 months.
What is Vireo Growth’s market cap?
Vireo Growth’s market cap is $420.10M.
When is Vireo Growth’s upcoming earnings report date?
Vireo Growth’s upcoming earnings report date is Aug 07, 2025 which is in 30 days.
How were Vireo Growth’s earnings last quarter?
Vireo Growth released its earnings results on May 09, 2025. The company reported -$0.018 earnings per share for the quarter, beating the consensus estimate of -$0.02 by $0.002.
Is Vireo Growth overvalued?
According to Wall Street analysts Vireo Growth’s price is currently Undervalued.
Does Vireo Growth pay dividends?
Vireo Growth does not currently pay dividends.
What is Vireo Growth’s EPS estimate?
Vireo Growth’s EPS estimate is 0.
How many shares outstanding does Vireo Growth have?
Vireo Growth has 925,467,830 shares outstanding.
What happened to Vireo Growth’s price movement after its last earnings report?
Vireo Growth reported an EPS of -$0.018 in its last earnings report, beating expectations of -$0.02. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Vireo Growth?
Currently, no hedge funds are holding shares in VREOF
Vireo Growth Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$0.55 (30.95% Upside)
$0.55 (30.95% Upside)
Blogger Sentiment
Bullish
VREOF Sentiment 70%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth $313.5K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-6.60%
12-Months-Change
Fundamentals
Return on Equity
-199.59%
Trailing 12-Months
Asset Growth
45.14%
Trailing 12-Months
Company Description
Vireo Growth
Vireo Health International, Inc. is a holding company, which engages in the cultivation, production, and sale of medical cannabis. Its products include medical marijuana extracts in the form of oils, vaporizers, and capsules. The company was founded on November 23, 2004 and is headquartered in Minneapolis, MN.
VREOF Company Deck
VREOF Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call conveyed a generally positive outlook, with several highlights including revenue growth, improved gross margin, and a strong financial position. The company is progressing well on merger transactions that are expected to enhance profitability. However, there were some lowlights such as sequential revenue decline and a decrease in property income.Read More>Technical Analysis
ZYUS Life Sciences
―
MTL Cannabis
―
Leef Brands
―
Refined Energy
―
Simply Solventless Concentrates Ltd
―